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Abstract
Background: Perinatal stroke occurs in more than 1 in 2,500 live births and resultant congenital hemiparesis
necessitates investigation into interventions which may improve long-term function and decreased burden of care
beyond current therapies (http://www.cdc.gov/ncbddd/cp/data.html). Constraint-Induced Movement Therapy
(CIMT) is recognized as an effective hemiparesis rehabilitation intervention . Transcranial direct current stimulation as
an adjunct treatment to CIMT may potentiate neuroplastic responses and improve motor function. The
methodology of a clinical trial in children designed as a placebo-controlled, serial –session, non-invasive brain
stimulation trial incorporating CIMT is described here. The primary hypotheses are 1) that no serious adverse events
will occur in children receiving non-invasive brain stimulation and 2) that children in the stimulation intervention group
will show significant improvements in hand motor function compared to children in the placebo stimulation control
group.
Methods/design: A randomized, controlled, double-blinded clinical trial. Twenty children and/or young adults
(ages 8–21) with congenital hemiparesis, will be enrolled. The intervention group will receive ten 2-hour sessions
of transcranial direct current stimulation combined with constraint-induced movement therapy and the control
group will receive sham stimulation with CIMT. The primary outcome measure is safety assessment of transcranial
direct current stimulation by physician evaluation, vital sign monitoring and symptom reports. Additionally, hand
function will be evaluated using the Assisting Hand Assessment, grip strength and assessment of goals using the
Canadian Occupational Performance Measure. Neuroimaging will confirm diagnoses, corticospinal tract integrity
and cortical activation. Motor cortical excitability will also be examined using transcranial magnetic stimulation
techniques.
Discussion: Combining non-invasive brain stimulation and CIMT interventions has the potential to improve motor
function in children with congenital hemiparesis beyond each intervention independently. Such a combined intervention
has the potential to benefit an individual throughout their lifetime.
Trial registration: Clinicaltrials.gov, NCT02250092Registered 18 September 2014
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Background
Based on data and statistics reported by the Center for
Disease Control, " Population-based studies from around
the world report prevalence estimates of CP ranging from
1.5 to more than 4 per 1,000 live births or children of a
defined age range. " Additionally, the lifetime costs of care
for an individial diagnosed with cerebral palsy is over 1
million dollars. (http://www.cdc.gov/ncbddd/cp/data.html)
[1]. Specific to children, hemiparesis or paralysis on one
side of the body, is most commonly caused by an ischemic
stroke or vascular disorder, and is often associated with
CP [1].
Significance of diagnosis
Many children with hemiparesis receive rehabilitation,
but our current interventions have a limited impact on
restoring function. The extended cost and utilization of
lengthy formal therapies such as bracing, casting, pharma-
cologic interventions and surgery can be painful, energy
consuming and resource depleting. Treatments such as
constraint-induced movement therapy (CIMT) have shown
significant improvements in motor function, yet the opti-
mal electrical current dosing in this population has yet to
be established [2] Impacting the recovery of a child during
critical periods of development with achievement of motor
milestones progressing into adulthood is imperative to
positively influence an individual who faces the challenges
of living with CP. Corticospinal system (CS) development
continues postnatally over the first few years of life, and
congenital impact or damage to the system before, during
or one year after birth can cause detriment to function
throughout the individual lifetime [2, 3] Although initially
this CS system develops bilaterally in typical development,
for those with a perinatal stroke, the integrity of the ipsilat-
eral projections is compromised and control of the limbs
occurs from the contralateral hemisphere. This loss is
driven by activity-dependent competition, between the two
hemispheres [4]. As an individual moves and explores the
environment through bimanual and unimanual activity,
the crossed corticospinal tract integrity gains strength.
Typical interhemispheric inhibition is progressively estab-
lished with potent interaction between the two hemi-
spheric motor cortices and accompanying corticospinal
activation and distinct unimanual function.
Critical barriers to progress in pediatric hemiparesis
If a child incurs a congenital unilateral infarct, the ipsile-
sional hemisphere may lose the developing crossed-
corticospinal tract integrity, while control of bilateral
movement may be dominated by the contralesional hemi-
sphere. This adaptation, however, can have a negative
impact on the quality and timing of hand function [5, 6].
Surviving neurons in the area of the stroke undergo an
imposed dormancy, influenced by the GABA-induced
inhibitory effects of the non-lesioned hemisphere; an
exaggerated interhemispheric inhibition. No longer does
the competition between the two sides exist equally, and
an imbalance of use and integrity of CS system occurs.
Additionally, in children with congenital hemiparesis who
incurred a stroke at or around the time of birth, “devel-
opmental disuse” may ensue, wherein the child utilizes
the unaffected hand primarily as the preferred hand,
with the affected hand utilized in more of an assisting
capacity [7, 8]. Without intervention compelling the af-
fected limb to engage in activity, the disability can
become continuously more profound and future recov-
ery less possible.
Promising potential
Encouragingly, the nervous system of a child is plastic
[9]."The ability to reestablish a balance between the two
hemispheres can therefore be exploited by the following
therapeutic interventions of 1) voluntary activation of the
involved hemiparetic limbs, 2) electrophysiologic decrease
in the exaggerated inhibitory activity of the nonlesioned
hemisphere upon the lesioned hemisphere, or 3) direct
electrophysiologic activation of the lesioned hemisphere
[3] Such potential has been seen, using combined inter-
ventions of CIMT and non-invasive brain stimulation
(NIBS) and as demonstrated through cortical excitability,
imaging and motor mapping studies [10]. This work
shows promise for outcomes in the pediatric population
with the positive potential to influence function through-
out the lifespan. Considerations of safety, cost and efficacy
are paramount, with further translational consideration of
clinical applicability.
CIMT
CIMT involves constraining the less-affected or non-
paretic upper extremity while activating the clinically
more-affected or paretic upper extremity through inten-
sive, structured manual therapy [11]. Day camp models,
wherein subjects engage in continuous training while
wearing a constraint, have been published previously
[12, 13] Such a design allows scheduling of therapy
content based on themes and activities within a group
setting. Subjects perform activities under the guidance of
a therapist or trained/supervised interventionist, with
incorporation of established goal setting and attainment.
NIBS- transcranial direct current stimulation
Transcranial direct current stimulation (tDCS) is cur-
rently being investigated as a neuromodulation interven-
tion [14] tDCS has shown beneficial motor behavioral
effects in adults [15] and is more cost effective and more
portable than another form of NIBS using electromag-
netic current called repetitive Transcranial Magnetic
Stimulation(rTMS). The mechanism of tDCS involves
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changing the spontaneous neuronal firing rate and
therefore the resting membrane threshold, influencing
polarization. Dependent upon the electrode montage
and dosing parameters, tDCS involves down-regulating
or inhibiting the excitability of the motor cortex in the
contralesional hemisphere in an effort to upregulate or
disinhibit the ipsilesional hemisphere. Applying cath-
odal tDCS to the contralesional hemisphere has been
shown to provide this inhibitory component in adults
with stroke, while anodal stimulation is excitatory,
leading to improved motor function. Importantly, chil-
dren with diagnoses such as Rasmussen’s Encephalitis,
and Schizophrenia have tolerated the use of tDCS well
with few minor adverse events such as the sensation of
tingling and no reports of pain [16, 17] tDCS has re-
cently been investigated in children with CP and more
specifically in our lab in children with unilateral spastic
CP with only minor adverse events found [18, 19]. No
serious adverse events, such as seizure, have occurred
with its use in child or adult populations [14, 20].
Adverse effects of tDCS have been minimized by main-
taining current intensity under 2.0 mA and current
duration under 20 min. A number of studies have
shown that the weak electrical currents applied across
the scalp in tDCS are not sufficient to cause tissue
damage in the cortex [ 21-23].
Modes of brain stimulation
As a point of clarity, tDCS should be distinguished from
other forms of brain stimulation. For example, trad-
itional electroconvulsive therapy (ECT) induces convul-
sive activity by delivery of large electrical currents for
the treatment of medically refractory depression. In
contrast, tDCS influences cortical neurons through the
process of neuromodulation, not by the induction of
action potentials. Thus, tDCS does not involve the major
risks associated with ECT, affecting memory and con-
sciousness. As compared to other non-invasive brain
stimulation techniques such as rTMS which carries a
low risk of seizure, there have been no reported cases of
tDCS inducing seizures either in healthy pediatric or
adult human subjects or in child and adult subjects with
various neurologic diagnoses[20, 22, 24].
Change in practice
The significance of this proposed study is that combined
CIMT and tDCS could translate research into unprece-
dented clinical gains in motoric function for individuals
with pediatric hemiparesis as 1) the brain during devel-
opmental years has a high capacity for plasticity, possibly
higher than in adults, 2) neuroplastic change can occur
in the injured brain, 3) we are applying a novel
neuromodulatory intervention specifically targeted for
brain reorganization, and 4) we are combining this
intervention with a current clinical behavioral approach
(CIMT) that has been shown to influence neuronal ex-
citability and make meaningful clinically important dif-
ferences.. This could potentially lead to a transformation
of rehabilitation practice for this condition Furthermore,
even if only a small percentage of the lifetime costs asso-
ciated with rehabilitating children with hemiparesis were
reduced, the aggregate savings would be significant.
Our protocol proposes to non-invasively apply an elec-
trophysiologic intervention with the clinically mature
therapy of CIMT. Changes in functional brain connect-
ivity after CIMT have been found in adults and chil-
dren[10, 25, 26]. However, little research has been
performed using non-invasive brain stimulation in
pediatric rehabilitation and even less with combined in-
terventions. This project combines a unique form of
noninvasive brain stimulation (tDCS) with a behavioral
treatment (CIMT) to promote a combined intervention
that could achieve higher recovery in pediatric hemipar-
esis than current treatment alone provides. Both modal-
ities impact excitability of the brain, yet this synergistic
approach is novel in children with hemiparesis. The proto-
col includes measurement of functional and morphologic
changes in the brain with neuroimaging and TMS testing
to show “proof of principle” data, enriching our under-
standing of connectivity and responders to intervention.
The expected outcomes are no serious adverse effects, im-
proved hand function, and improved functional connectiv-
ity of the affected hemisphere.
Methods/design
Ethical considerations
This study has been approved by the University of
Minnesota and Gillette Children’s Specialty Healthcare
Institutional Review Boards. Approval by the University of
Minnesota Clinical and Translational Science Institute
(UMN CTSI) and its Scientific Review Committee, as well
as Center for Magnetic Resonance Research (CMRR), was
also obtained. All caregivers and children will be given
oral and written information about the study before a
request for formal informed consent/assent is signed.
Objectives
The primary objective of the proposed project is to deter-
mine the feasibility of the study design as well as to assess
the synergistic effect of combined tDCS/CIMT on safely
improving hand motor function in children and young
adults between the ages of 8 and 21 with hemiparesis.
Hypotheses
1. Childrenwithhemiparesis randomized to intervention
(tDCS/CIMT)or control (shamtDCS/CIMT)will not
display any seizureactivity orother serious adverse effect.
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2. The intervention group will show greater improvement
in paretic hand function (force production, speed,
quality of movement) than will controls.
3. The intervention group will show greater
improvements in self-reported levels of participation
and satisfaction with rehabilitation goals as evidenced
by the COPM.
The secondary objective is to examine the influence
of combined tDCS/CIMT on brain excitability and
reorganization.
Hypotheses
1. Children in the tDCS/CIMT group will show
significantly greater excitability in the ipsilesional
hemisphere than will controls.
2. Changes in brain excitability and reorganization
will correlate with positive changes in motor
function.
Study design
The study will use a randomized, sham-controlled,
pretest-posttest-follow up design involving two groups
of 10 children with hemiparesis and unilateral infarct or
periventricular leukomalacia as confirmed by MRI (total
sample size = 20). (Fig. 1). This protocol is registered on
clinicaltrials.gov (# NCT02250092)
Recruitment
We will use our established database of over 200 families
to begin recruitment of children with hemiparesis, plus
talks at local pediatric facilities, mailings, posting on
related websites and newsletters. Incorporation of CIMT
Fig. 1 Flowchart of tDCS/CIMT study adapted from the Consolidated Standards of Reporting Trials (CONSORT). AHA: Assisting Hand Assessment,
CIMT: Constraint-Induced Movement Therapy, COPM: Canadian Occupational Performance Measure, DTI: Diffusion Tensor Imaging, MRI: Magnetic
Resonance Imaging, rs-fMRI: resting-state functional Magnetic Resonance Imaging, tDCS: transcranial Direct Current Stimulation, TMS: Transcranial
Magnetic Stimulation
Gillick et al. BMC Pediatrics  (2015) 15:178 Page 4 of 10
provides a motor training component to the study, and
families are more willing to participate with the promise
of receiving what would be an otherwise expensive inter-
vention now covered by the study.
Participants- inclusion and exclusion criteria
Children and young adults, ages 8–21, with hemiparesis
due to perinatal stroke or periventricular leukomalacia
will be recruited for the study based on the following
eligibility criteria:
Inclusion criteria
Subjects will be eligible to participate in the study if the
following conditions exist:
1. Hemispheric Stroke or Periventricular Leukomalacia
confirmed by most recent MRI or CT radiologic
report with resultant congenital hemiparesis
2. ≥ 10 degrees of active motion at the
metacarpophalangeal joint
3. No evidence of seizure activity within the last
2 years
4. Presence of a motor evoked potential from at least
the contralesional hemisphere if not both
hemispheres
5. Ages 8–21 years
6. If ages 8–17, able to give informed assent along with
the informed consent of the legal guardian
7. Children who have had surgeries, which may
influence motor function e.g.- tendon transfer, will
be included, yet surgical history will be documented
Exclusion criteria
Subjects will be excluded from participation in the study




4. Disorders of Cellular Migration and Proliferation
5. Acquired Traumatic Brain Injury
6. Pregnancy
7. Indwelling metal or incompatible medical devices
8. Evidence of skin disease or skin abnormalities
9. Botulinum toxin or Phenol block within the last six-
months
Prior and concomitant therapy
Behavioral therapies including occupational, physical or
speech therapies will be allowed both during both the
intervention and follow-up period. These therapies will
be documented and reported.
Exit criteria
Subjects will exit the study if any of the following condi-
tions exist:
1. Subject voluntarily withdraws from the study.
2. Subject acquires any of the listed exclusion criteria.
3. Subject completes the protocol.
4. Subject’s well-being, in the opinion of the Investigator,
would be compromised by study continuation.
5. Subject experiences a serious adverse event or
seizure.
6. Medical monitor and/or IRB recommendation
Randomization
Each child will be randomized to either the real (interven-
tion) or sham (control) tDCS arm of the study. The
randomization will be done by means of sealed envelopes
constructed by the study biostatistician using a random
number generator. The study coordinator will assign en-
velopes, in numerical order, to the subjects upon their
randomization.
Blinding
The investigator who performs the testing, the CIMT
interventionists and the physician who does the
evaluations will be blinded to the treatment arm as
will the child/caregiver/family. The study biostatisti-
cian, study coordinator and principal investigator (PI)
will be unblinded. The following procedure will be
employed:
1. The study biostatistician will provide sealed
envelopes to the study coordinator.
2. The study coordinator will share the group
assignment with the principal investigator in a
secure private room, in the absence of the physician,
research tester, subject legal guardian and subject.
The Medical Monitor to the study will have access
to the group assignment.
3. Blinding is applied through designated settings on
the tDCS machine of sham or real tDCS. The
unblinded investigator who administers the tDCS
(PI: BTG) will, during the intervention, switch the
setting on the tDCS device to the designated
placebo setting, hidden from view of the subject. For
the first 30-seconds of either setting, a gradual
“ramp-up” sensation of the stimulation occurs. This
is built into the machine for both settings. However,
for the sham stimulation, the sensation then abates,
and not until the end of the 20-minute session does
the subject receiving the 30-seconds of “ramp-down”
sham once again experience the sensation. The
sensation then occurs and “ramps-down” the
amperage until the machine turns off.
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4. Information on subject group assignment will be
logged and stored in a designated locked cabinet at
the study coordinators office.
Outcome Assessments. We incorporated the body func-
tion/structure and activity/participation domains of the
International Classification of Functioning, Disability and
Health [2727].
Primary outcome measure
The Assisting Hand Assessment (AHA) scaled score will
be used as the primary outcome measure as a test of
unilateral limb dysfunction; it is based on a child’s usual
performance in relevant activities. This test uses a stan-
dardized video-recorded play session. Activity is assessed
on 22 items using a 4-point rating scale. The range of
raw scores is 22–88 points, with higher scores indicating
better ability. Excellent interrater (0.97) and intrarater
(0.99) reliability has been found using this tool and it
has been found to have high validity in use with chil-
dren[28-30]
Secondary outcome measures
The Canadian Occupational Performance Measure
(COPM) is an individualized outcome measure used to
detect changes in the self-perception of the client’s per-
formance and satisfaction over time by identifying diffi-
culty in performance of specific activities [31, 32]. The
tool is a self-reported ordinal scale score which encom-
passes domains in impairments, body structure, activity,
activity limitations, participation restrictions and envir-
onmental factors which an individual experiences. Test-
retest reliability has been found to be strong in the do-
mains of performance (r = 0.89) and satisfaction (0.88).
Grip strength will also be measured using hand
dynamometry[33].
Sample size/power
Power calculations for the primary outcome measure
AHA scaled score difference between pre- and post-test
measurements used the sample size formula for nor-
mally distributed statistics with a type I error level of α
(2-sided test) and power of (1-β):
n ¼ V ðZð1−∝=2Þ þ Z 1−βð ÞÞ2
Δ2
where Δ denotes the minimal clinically important dif-
ference (MCID) to detect, n denotes the sample size per
group, and V denotes the variance of the test statistic.
For ANCOVA analyses, V = 2(σ^2)(1-ρ^2) where σ^2 is
the (average) variability and ρ is the (average) correlation
between pre- and post-treatment measurements [34, 35].
Power (1-β) was computed for 10 patients per treatment
group across a range of possible values for the correl-
ation with alpha equal to 0.05. These are computed for
an MCID of 2.4, and for the rTMS/CIMT study treat-
ment effect of 5.4, which is considered a reasonable esti-
mate for this tDCS exploratory study [36]. The standard
deviation from the rTMS/CIMT study was used as an
estimate for the power calculations and was equal to 4.7.
In addition, 1.5 times the standard deviation of the
rTMS/CIMT study was also used in the power calcula-
tions to provide power estimates within a conservative
standard deviation. The correlation between pre- and
post-treatment AHA scores in the rTMS study was 0.97.
Based on a correlation of 0.8 and using the conservative
standard deviation of 7.1, we will have 80 % power to
detect the difference of 5.4 between treatment groups.
Study protocol
Children will be randomized into two groups: real tDCS/
CIMT (intervention) or sham tDCS/CIMT (control). The
children will receive 10 continuous weekday sessions of
tDCS and CIMT. (Fig. 2) To clarify, we will include only
children in whom we can elicit a motor evoked potential
(MEP) using TMS applied to the ipsilesional hemisphere.
Although by doing so we limit greatly the number of chil-
dren whom we can include, such conservatism is neces-
sary to proceed in a safe and informed manner with
sufficient awareness of the functional topography of each
subject’s brain.
Rationale for use of tDCS Our previous research incor-
porated rTMS, which although promising as an inter-
vention, has limitations especially with children [36, 37].
Our recent results demonstrate not only safety and but
also reveal significant improvements in hand function
with rTMS combined with constraint-induced move-
ment therapy, yet we foresee the possible greater bene-
fits from using tDCS over this type of non-invasive brain
stimulation in pediatric hemiparesis. (REF) First, both of
the interventions, tDCS and CIMT, applications of tDCS/
CIMT can occur concurrently whereas it is difficult to
incorporate the use of rTMS at the same time as perform-
ing behavioral therapy with the affected upper extremity.
Applying tDCS/CIMT simultaneously could optimize neu-
roplastic principles of concurrent firing of neurons and
strengthening of neuronal networks [38, 39]. Second,
tDCS may reduce costs. As rTMS can be ten times the
current cost of tDCS, cost may become prohibitive
when considering rTMS. Additionally, if the application
of tDCS reduces the need for additional therapies, a
further costs savings could be realized. Third, use of
rTMS has resulted in reports, albeit rare, of adverse
events such as seizures and syncopal episodes, in both
adults and children [40, 41] .
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In addition to its economy and portability, tDCS has
shown improvements in motor function in adults with
and without the concurrent use of CIMT [42, 43]. The
rationale for the investigation of tDCS in the pediatric
population is that the use of non-invasive brain stimula-
tion could translate more efficiently into clinical applica-
tions thus improving the quality of life for children with
hemiparesis. And tDCS safety, when using standard
guidelines, is supported in the literature as to having
common side effects limited to mild and reversible skin
irritation. Specific to the tDCS model we are using
(Soterix LTE 1×1 tDCS, NY, NY), the design reduces
skin irritation by conditioning the skin prior to stimula-
tion and allowing the device operator to incorporate
subject feedback and adjust the controls without stop-
ping. This model was specifically chosen for our project
because of its adaptability to resistance changes between
the surface electrodes and the subject. The model uses
two 9 V batteries to administer stimulation. As a safety
feature, the unit will automatically reduce the applied
voltage so as to maintain a low voltage level. The built-
in ramp-up and ramp-down features allow for gradual
administration of the current. Another component of
this device specifically designed for children is the
adjustable strap that allows for optimal contact of the
surface electrodes with the skin for reduced irritation.
Safety. Safety testing includes a physician screening
with a modified pediatric stroke outcome measure at
pretest, interim day 5, posttest and follow-up sessions.
Additionally, vital signs are assessed before and after
each tDCS/CIMT session and subjects and caregivers
complete a subject report of symptoms and a tolerance
survey.
Corticospinal tract integrity using MRI Sequences.
Resting state fMRI (rs-fMRI) and Diffusion Tensor
Imaging (DTI) techniques are becoming alternatives to
more traditional task fMRI and structural MRI scans to
demonstrate functional and structural connectivity in
the brain, particularly in pediatric patients who may be
challenged by participating in task based fMRI studies.
Our previous work revealed cortical volume differences
in children with hemiparesis; further investigation using
connectivity metrics may provide a better understanding
of the integrity of the corticospinal tract in congenital
hemiparesis. Subjects will be scanned at UMN Center
for Magnetic Resonance Research on a Siemens 3 T
system to obtain a) T1-weighted structural MPRAGE
with a 1 mm isotropic spatial resolution; b) High angular
resolution multi-band diffusion imaging (HARDI) with
whole-brain coverage, 90 slices with 1.5 mm isotropic
spatial resolution, b-values of,1000 and 2000 s/mm2 with
64 gradient directions per b value, and 16 additional non-
diffusion weighted images and c) Resting-state multi-band
based functional MRI will be obtained with whole
brain coverage, 72 slices with 2 mm isotropic slices,
TR = 730 ms, and 500 time points in 6 min. The
complete dataset will be obtained in less than 45 min,
taking into account time required for setup and comfort-
able installation of the child in the scanner. Resting-state
fMRI data will be processed using independent compo-
nent analysis (ICA) to identify the sensory-motor area. Ac-
tivation areas on the baseline scans will be used to refine
the site of tDCS and identify seed areas for tractography.
Excitability Measurements using TMS. TMS (Magstim,
Dyfed, UK) will be used to measure corticospinal excit-
ability in the ipsilesional and contralesional hemispheres.
TMS will be delivered with a 70-mm figure-of-eight coil,
tangential to head with handle aligned 45 degrees
lateral. The assessment will incorporate single-pulse
motor threshold, 1 mV and cortical silent period test-
ing. TMS measurements of cortical excitability guided
by stereotactic neuronavigation (Brainsight, Rogue Re-
search, Montreal, QC, Canada), will be employed to create
a map of the motor cortex from anatomical MRI images
obtained at the CMRR. The co-registration of the TMS
coil position on the head with the MRI obtained image of
the brain anatomy will allow precision in children who
have neurologic lesions. All TMS testing will occur in the
UMN CTSI by the PI. For this, the child will be seated in
a child-sized reclining chair. Surface electromyographic
(EMG) electrodes will be attached over the first dorsal
interosseous muscles bilaterally, which will record the
motor evoked potentials (MEP) resulting from the mag-
netic stimulation to the M1 region of each hemisphere.
Next, the resting motor threshold (RMT) for TMS activa-
tion of the target muscle will be determined, and the loca-
tion of the hotspot defined. If a threshold cannot be
elicited within at least the contralesional hemisphere (i.e.,
Fig. 2 Study design. CIMT, Constraint-Induced Movement Therapy; mos, months; tDCS, Transcranial Direct Current Stimulation
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no hotspot), the subject will be excluded from the study as
position of the tDCS electrodes will be influenced. The
RMT will be defined as the lowest amount of stimulation
inducing an MEP of at least 50uV on at least 3 of 5 stimu-
lations Cortical excitability will also be tested by adminis-
tration of 10 TMS pulses, at the minimum stimulus
intensity to produce MEPs of 1 mV [44].
CSP will be determined by the subject exerting finger
extensor contraction at approximately 30 % of maximum,
as guided by a force tracing on a computer display, while
a single TMS pulse at an intensity of 150 % of RMT is
delivered to the ipsilesional M1 cortex [45, 46]. The result-
ant CSP will be measured from the onset of the first peak
of the MEP to resumption of surface EMG activity with a
threshold value of 50 % mean prestimulus amplitude [47].
Intervention
tDCS/CIMT intervention group Children randomly
assigned to this group will receive 10 sessions of both
tDCS and CIMT on concurrent days over a span of two
weeks. As supported by results from our previous com-
puterized modeling pilot, the subject will receive tDCS
at the motor hotspot at 0.7 mA current intensity for
20 min [19]. In a primary motor cortex (M1)/supra-
orbital (SO) montage, the anode will be positioned over
the ipsilesional supraorbital region and the cathode posi-
tioned over contralesional motor hotspot to induce
contralesional cortical inhibition. During this 20 min
session, the subject will be involved in CIMT for the
paretic hand and arm using a sling. The sling will be
applied for a 2-hour period, which incorporates the
20 min tDCS session. The CIMT will be given to the
subject on an individual basis for two hours each CIMT
treatment day by a CIMT-trained therapist/intervention-
ist. The CIMT treatments will be standardized, consist-
ing of shaping activities for function, range of motion
and strengthening of the paretic upper extremity. In
addition, children will continue to use their paretic limb
during functional activities at home and during a caregiver-
supervised home program. This combined treatment of
tDCS and CIMT will continue until 10 weekday sessions
are completed over the two-week period.
tDCS/CIMT control group Children in this group will
receive the same procedures and home program as the
intervention tDCS/CIMT group but, the tDCS device
will be set to a specific placebo setting which extin-
guishes the current after a 30 s to 1 min ramp-up phase
and gradually reintroduces the ramp-down at the end of
the 20 min session. This feature allows for placebo
control and blinding.
Statistical Analysis. There are 3 analysis populations
planned. Intent-to-treat (ITT) will include any subject ran-
domized according to their treatment assignment. Per-
protocol (PP) will include randomized subjects without
major protocol violations and who were compliant (at least
80 % of planned sessions with their treatment assignment.
A detailed list of the major protocol violations warranting
exclusion from the PP analysis will be determined prior to
trial commencement. The Safety population will include all
subjects who receive treatment, according to treatment re-
ceived. We do not anticipate these groups to differ. The
safety profile will use the safety population and be primar-
ily descriptive in nature reporting the number and percent-
age of adverse events for the two treatment groups and
include an aggregate breakdown by severity, seriousness,
and frequency (within a patient). Within-group analysis of
continuous outcomes comparing posttest to pretest will be
done with paired t-tests. Between-group analysis of con-
tinuous outcomes comparing the mean change from pre-
test to posttest between treatment groups will be adjusted
for baseline values in the fashion of ANCOVA for added
precision. The primary analysis will be based on the ITT
population with complementary analyses using the PP
population. The association between changes in brain
excitability/reorganization and motor function will also be
evaluated and based on linear regression. P-values less than
0.05 will be considered statistically significant.
Discussion
We outline the background and design of a trial with two
intervention groups comparing the effects of tDCS on
children and young adults with hemiparesis receiving
CIMT. The design of this study is predicated upon posi-
tive outcomes previously established with CIMT. Add-
itionally, we incorporate consideration of trials we have
completed with neuromodulation interventions of repeti-
tive transcranial magnetic stimulation and a tDCS pilot
with this population [19, 36, 48]. The proposed study de-
sign pursues investigation of a synergistic effect achieved
by combining rehabilitation (CIMT) and neuromodulatory
(tDCS) interventions. The study hypotheses reflect the im-
portance of safety, feasibility and efficacy surrounding this
dual intervention. As non-invasive brain stimulation in
pediatric hemiparesis is in a nascent investigational phase,
understanding the potential value of such interventions is
paramount.
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